Research Articles

Explore upcoming scientific meetings and educational events focused on advancing collaboration, sharing new evidence, and strengthening best practices in the care of patients with cancer-related cardiovascular conditions.

Young woman with breast cancer and cardiotoxicity with severe heart Failure treated with a HeartMate II™ for nearly six years prior to heart transplantation.

Authors:

Sundbom P, Hedayati E, Peterzen B, Granfeldt H, Ahn H, Hubbert L.

Publication:

ASAIO Journal

Date:

2014 Sep 17

Article Link

Twisting and ironing: Doxorubicin cardiotoxicity by mitochondrial DNA damage.

Authors:

Nitiss KC, Nitiss JL.

Publication:

Clinical Cancer Research

Date:

2014 Sep 15

Article Link

Treatment-related cardiotoxicity in survivors of childhood cancer.

Authors:

Lipshultz SE, Cochran TR, Franco VI, Miller TL.

Publication:

Nature Reviews Clinical Oncology

Date:

2013 Dec

Article Link

Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.

Authors:

van Dalen EC, Raphaël MF, Caron HN, Kremer LC.

Publication:

Cochrane Database Systematic Review

Date:

2014 Sep 4

Article Link

Trastuzumab-related cardiotoxicity among older patients with breast cancer.

Authors:

Chavez-MacGregor M, Zhang N, Buchholz TA, Zhang Y, Niu J, Elting L, Smith BD, Hortobagyi GN, Giordano SH.

Publication:

Journal of Clinical Oncology

Date:

2013 Nov 20

Article Link

Trastuzumab alters the expression of genes essential for cardiac function and induces ultrastructural changes of cardiomyocytes in mice.

Authors:

ElZarrad MK, Mukhopadhyay P, Mohan N, Hao E, Dokmanovic M, Hirsch DS, Shen Y, Pacher P, Wu WJ.

Publication:

PLos One

Date:

2013 Nov 8

Article Link

The risk of toxicities from trastuzumab, alone or in combination, in an elderly breast cancer population.

Authors:

Adamo V, Ricciardi GR, Adamo B, Ferraro G, Franchina T, Rossello R, Zanghì M, Cicero G, Rizzo S, Caristi N, Russo A.

Publication:

Oncology

Date:

2014

Article Link

Sympathetic nervous system alterations with HER2+ antagonism: an early marker of cardiac dysfunction with breast cancer treatment?

Authors:

Lenneman CG, Abdallah WM, Smith HM, Abramson V, Mayer IA, Silverstein C, Silverstein C, Means-Powell J, Paranjape SY, Lenihan D, Sawyer DB, Raj SR.

Publication:

Ecancermedicalscience

Date:

2014 Jul 17

Article Link

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

Authors:

Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N.

Publication:

Pediatric Blood and Cancer

Date:

2014 Aug 30

Article Link

Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).

Authors:

Ewer M, Gianni L, Pane F, Sandri MT, Steiner RK, Wojnowski L, Yeh ET, Carver JR, Lipshultz SE, Minotti G, Armstrong GT, Cardinale D, Colan SD, Darby SC, Force TL, Kremer LC, Lenihan DJ, Sallan SE, Sawyer DB, Suter TM, Swain SM, van Leeuwen FE.

Publication:

Ecancermedicalscience

Date:

2014 May 29

Article Link